Applications are open from 10 Oct 2022 – 31 Jan 2023 for the PHOENIX-OITB Open Call!
PHOENIX-OITB’s mission is to offer a Single-Entry-Point for a consolidated network of facilities, technologies, services and expertise for all the technology transfer aspects from characterization, testing, verification up to scale-up, GMP compliant manufacturing and regulatory guidance in the field of nanopharmaceutical development, framing the OITB clearly within the nanomedicine field.
The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. Under the scope of the Open Call, we offer the following service categories:
- Physico-Chemical Characterization,
- In vitro Characterisation,
- In vivo Characterisation and
How to apply
Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.
The Evaluation Committee will evaluate each proposal in three main criteria:
The applicants will be informed about the decision made by the Evaluation Committee by the end of 01.03.2023 via email. A Stage 2 detailed application must then be submitted by 31.03.2023. Awarded projects must be completed by February 2025.
For more information and all application documents, visit our website.